A retrospective cohort study of bladder cancer following the COVID-19 pandemic: Are patients presenting with more aggressive disease?

BACKGROUND: The COVID-19 pandemic has resulted in delays in the treatment of patients with urological malignancies. The management of bladder cancer (BC) in particular poses a significant challenge given the recurrent nature of the disease and the intense follow-up regime required for many cases. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Steven, Rigney, Kate, Hayes, Leah, Ryan, Paul Christopher, Chaitanya, Vishwa, Jacob, Prem Thomas, Abdelrahman, Mamoun, Giri, Subhasis K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387060/
https://www.ncbi.nlm.nih.gov/pubmed/35996636
http://dx.doi.org/10.1016/j.amsu.2022.104430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387060/
https://www.ncbi.nlm.nih.gov/pubmed/35996636
http://dx.doi.org/10.1016/j.amsu.2022.104430

Ejemplares similares